[Infections and liver cirrhosis]

Miriam Dibos,Ulrich Mayr,Julian Triebelhorn,Roland M Schmid,Tobias Lahmer
DOI: https://doi.org/10.1007/s00063-024-01168-2
Abstract:End-stage liver disease is a life-threatening clinical syndrome combined with a state of immune dysfunction. In this constellation patients are prone to bacterial, fungal and viral infections associated with markedly increased morbidity and mortality rates. Bacterial infections are the most prevalent kind of infection in patients with end-stage liver disease accounting for nearly 30%. The evolving rates of multidrug resistant organisms present enormous challenges in treatment strategies. Therefore, the urgent needs for prevention, early detection strategies and widespread treatment options are a necessity to handle the rising incidence of infection complications in end-stage liver disease.
What problem does this paper attempt to address?